Literature DB >> 8751414

Preoperative radiotherapy in rectal carcinoma--aspects of acute adverse effects and radiation technique.

G J Frykholm1, U Isacsson, K Nygård, A Montelius, B Jung, L Påhlman, B Glimelius.   

Abstract

PURPOSE: To explain a possible association between treatment technique and postoperative mortality after preoperative radiotherapy of rectal carcinoma, the dose distributions were compared in model experiments. METHODS AND MATERIALS: Preoperative radiotherapy with a three-beam technique delivered in five fractions to 25 Gy (5 Gy/daily for 5 or 7 days) was given to patients with primary resectable rectal carcinoma. The adverse effects of this treatment, both acute and late, have been low. In a parallel trial using an identical fractionation schedule and total dose but with a two-beam technique, the postoperative mortality was higher. Two-, three-, and four-beam techniques were analyzed in 20 patients with computed tomography based, three-dimensional dose planning. Dose distributions and dose-volume histograms in the planning target volume (PTV) and in the organs at risk were considered. A numerical "biological" model was used to compare the techniques.
RESULTS: The two-beam and the four-beam box techniques give the most homogeneous dose distributions in the PTV, although all techniques result in dose distributions that would be considered adequate, provided 16 MV or higher photon energies are used. Three- and four-beam techniques show advantages over the two-beam technique with respect to organs at risk, particularly the small bowel. With the two-beam technique and the upper beam limit at mid-L4, the volume of the bowel that receives > 95% of the prescribed dose, and hence, is included in the treated volume (TV), is more than twice as large as that with three- and four-beam techniques, and that of the total body between 1.5 and 2 times as large. The results of the analyses using the biological model indicate that the three- and four-beam techniques result in less small bowel complication rates than the two-beam technique. The integral energy to the total body is similar for all treatment modalities compared.
CONCLUSIONS: The volume of bowel included in the TV, rather than the energy imparted to the body, influences postoperative mortality, and emphasizes the importance of precise radiotherapy planning to minimize normal tissue toxicity.

Entities:  

Mesh:

Year:  1996        PMID: 8751414     DOI: 10.1016/0360-3016(96)00229-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer.

Authors:  Hiroshi Doi; Naohito Beppu; Takashi Kato; Masashi Noda; Hidenori Yanagi; Naohiro Tomita; Norihiko Kamikonya; Shozo Hirota
Journal:  Mol Clin Oncol       Date:  2015-07-21

Review 2.  Update on advances and controversy in rectal cancer treatment.

Authors:  S Biondo; D Fraccalvieri; T Golda; R Frago; L Trenti; E Kreisler
Journal:  Tech Coloproctol       Date:  2016-01-12       Impact factor: 3.781

3.  Pre-operative radiochemotherapy of locally advanced rectal cancer.

Authors:  Xiao-Nan Sun; Qi-Chu Yang; Jian-Bin Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.

Authors:  Ly Do; Nisar Syed; Ajmel Puthawala; Samar Azawi; Imad Shbeeb; I-Yeh Gong
Journal:  Gastrointest Cancer Res       Date:  2011-05

5.  Late complications after proctectomy in rectal cancer patients who underwent radiotherapy.

Authors:  So Hyun Kim; Jae Hwang Kim; Sang Hun Jung
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

Review 6.  Late small bowel toxicity after adjuvant treatment for rectal cancer.

Authors:  Matthias Guckenberger; Michael Flentje
Journal:  Int J Colorectal Dis       Date:  2005-07-29       Impact factor: 2.571

7.  Histologic response after neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma: experience from Sudan.

Authors:  Ahmed Abd Elrahman Abdalla; Awad Ali M Alawad; Hussein Abdalla M Ali
Journal:  Afr Health Sci       Date:  2016-09       Impact factor: 0.927

8.  Dose Escalation with Simultaneous Integrated Boost (SIB) Using Volumetric Modulated Arc Therapy (VMAT) in Rectal Cancer.

Authors:  Abdullah Alsuhaibani; Ahmed Elashwah; Rana Mahmood; Alaa Abduljabbar; Samar Alhomoud; Luai Ashari; Shouki Bazarbashi; Ali Aljubran; Ahmed Alzahrani; Muhamed Mohiuddin; Hadeel Almanea; Hussah Alhussaini; Nasser AlSanea
Journal:  J Gastrointest Cancer       Date:  2018-07-14

9.  Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 Gy) and intraoperative radiation therapy (15 Gy) in patients with primarily resectable pancreatic cancer - NEOPANC.

Authors:  Falk Roeder; Carmen Timke; Ladan Saleh-Ebrahimi; Lutz Schneider; Thilo Hackert; Werner Hartwig; Annette Kopp-Schneider; Frank W Hensley; Markus W Buechler; Juergen Debus; Peter E Huber; Jens Werner
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

10.  Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.

Authors:  Robson Ferrigno; Paulo Eduardo Ribeiro dos Santos Novaes; Maria Letícia Gobo Silva; Ines Nobuko Nishimoto; Wilson Toshihiko Nakagawa; Benedito Mauro Rossi; Fábio de Oliveira Ferreira; Ademar Lopes
Journal:  Radiat Oncol       Date:  2006-03-28       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.